Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Net Income towards Common Stockholders for 4 consecutive years, with $601.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 16.64% year-over-year to $601.0 million, compared with a TTM value of $2.2 billion through Dec 2025, up 8.08%, and an annual FY2025 reading of $2.1 billion, up 4.57% over the prior year.
  • Net Income towards Common Stockholders was $601.0 million for Q4 2025 at GE HealthCare Technologies, up from $465.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $721.0 million in Q4 2024 and bottomed at $189.0 million in Q1 2023.
  • Average Net Income towards Common Stockholders over 4 years is $465.5 million, with a median of $467.5 million recorded in 2024.
  • The sharpest move saw Net Income towards Common Stockholders crashed 51.41% in 2023, then skyrocketed 97.88% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at $555.0 million in 2022, then dropped by 27.39% to $403.0 million in 2023, then soared by 78.91% to $721.0 million in 2024, then fell by 16.64% to $601.0 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for GEHC at $601.0 million in Q4 2025, $465.0 million in Q3 2025, and $500.0 million in Q2 2025.